Standardizing creatinine measurements, facilitating digital access to eGFR calculators, conducting studies for local reference values, promoting alternative markers like cystatin C, and individualizing the use of eGFR formulas based on patient needs can improve CKD diagnosis and management in Mexico and Latin America. Here, CST3 is linked to chronic kidney disease.